For research use only. Not for therapeutic Use.
(±)-SLV319(CAT: I013658) is the racemic form of SLV319, a potent and selective cannabinoid-1 (CB1) receptor antagonist with an IC50 of 22 nM. By targeting CB1 receptors, it modulates the endocannabinoid system, influencing pathways involved in appetite regulation, energy balance, and metabolic disorders. (±)-SLV319 is particularly valuable in metabolic and neurological research, where it supports the exploration of therapeutic strategies for conditions such as obesity, type 2 diabetes, and addiction. Its high specificity and efficacy make it a critical tool for studying CB1 receptor signaling and its implications in disease mechanisms.
| Catalog Number | I013658 |
| CAS Number | 362519-49-1 |
| Molecular Formula | C₂₃H₂₀Cl₂N₄O₂S |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | DMSO: ≥ 31 mg/mL |
| IUPAC Name | 5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N//'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide |
| InChI | InChI=1S/C23H20Cl2N4O2S/c1-26-23(28-32(30,31)20-13-11-19(25)12-14-20)29-15-21(16-5-3-2-4-6-16)22(27-29)17-7-9-18(24)10-8-17/h2-14,21H,15H2,1H3,(H,26,28) |
| InChIKey | AXJQVVLKUYCICH-UHFFFAOYSA-N |
| SMILES | CN=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4 |
